We identified that Lactobacillus is the dominant genus in the oral cavity and Lactobacillus metabolites slowed the OPC progression by activating GPR43 to increase the number of tumor-infiltrating CD8+ T cells, indicating that supplementation of specific microbiota and metabolite may have an impact on future cancer therapy. The gene discussed is CD8A; the disease is neoplasm.